[1]
|
Radue, R., Walaszek, A. and Asthana, S. (2019) Neuropsychiatric Symptoms in Dementia. Handbook of Clinical Neu-rology, 167, 437-454. https://doi.org/10.1016/B978-0-12-804766-8.00024-8
|
[2]
|
Alzheimer’s Association. (2022) 2022 Alzheimer’s Disease Facts and Figures. Alzheimer’s Dementia: The Journal of the Alzheimer’s Association, 18, 700-789. https://doi.org/10.1002/alz.12638
|
[3]
|
Li, X., Feng, X., Sun, X., Hou, N., Han, F. and Liu, Y. (2022) Global, Regional, and National Burden of Alzheimer’s Disease and Other Dementias, 1990-2019. Frontiers in Aging Neuroscience, 14, Article 937486.
https://doi.org/10.3389/fnagi.2022.937486
|
[4]
|
van de Veen, D., Bakker, C., Peetoom, K., Pijnenburg, Y., Papma, J., PRECODE Study Group, de Vugt, M. and Koopmans, R. (2022) Provisional Consensus on the Nomenclature and Operational Definition of Dementia at a Young Age, a Delphi Study. International Journal of Geriatric Psychiatry, 37. https://doi.org/10.1002/gps.5691
|
[5]
|
Tondelli, M., Chiari, A., Vinceti, G., Galli, C., Salemme, S., Filippini, T., Carbone, C., Minafra, C., De Luca, C., Prandi, R., Tondelli, S. and Zamboni, G. (2023) Greenness and Neuropsychiatric Symptoms in Dementia. Environmental research, 242, Article ID: 117652. https://doi.org/10.1016/j.envres.2023.117652
|
[6]
|
Carrarini, C., Russo, M., Dono, F., Barbone, F., Rispoli, M.G., Ferri, L., Di Pietro, M., Digiovanni, A., Ajdinaj, P., Speranza, R., Granzotto, A., Frazzini, V., Thomas, A., Pilotto, A., Padovani, A., Onofrj, M., Sensi, S.L. and Bonanni, L. (2021) Agitation and Dementia: Prevention and Treatment Strate-gies in Acute and Chronic Conditions. Frontiers in Neurology, 12, Article 644317. https://doi.org/10.3389/fneur.2021.644317
|
[7]
|
Zuidema, S.U., Derksen, E., Verhey, F.R. and Koopmans, R.T. (2007) Prevalence of Neuropsychiatric Symptoms in a Large Sample of Dutch Nursing Home Patients with Dementia. International Journal of Geriatric Psychiatry, 22, 632-638. https://doi.org/10.1002/gps.1722
|
[8]
|
Oh, Y.S., Kim, J.H., Yoo, S.W., Hwang, E.J., Lyoo, C.H., Lee, K.S. and Kim, J.S. (2021) Neuropsychiatric Symptoms and Striatal Monoamine Availability in Early Parkinson’s Disease without Dementia. Neurological Sciences, 42, 711-718. https://doi.org/10.1007/s10072-020-04859-8
|
[9]
|
Alb’ool, B. and Abu Khait, A. (2023) The Presence and Severity of Neuropsychiatric Symptoms and Their Association with Quality of Life among Patients with Dementia. Cognitive Neuropsychiatry, 28, 307-325.
https://doi.org/10.1080/13546805.2023.2255342
|
[10]
|
Patrick, K.S., Gunstad, J., Martin, J.T., Chapman, K.R., Drost, J. and Spitznagel, M.B. (2022) Specific Agitation Behaviours in Dementia Differentially Contribute to Aspects of Caregiver Burden. Psychogeriatrics, 22, 688-698.
https://doi.org/10.1111/psyg.12871
|
[11]
|
Cummings, J., Mintzer, J., Brodaty, H., Sano, M., Banerjee, S., Devanand, D.P., Gauthier, S., Howard, R., Lanctôt, K., Lyketsos, C.G., Peskind, E., Porsteinsson, A.P., Reich, E., Sampaio, C., Steffens, D., Wortmann, M., Zhong, K. and International Psychogeriatric Association (2015) Agitation in Cognitive Dis-orders: International Psychogeriatric Association Provisional Consensus Clinical and Research Definition. International Psychogeriatrics, 27, 7-17.
https://doi.org/10.1017/S1041610214001963
|
[12]
|
Cummings, J., Sano, M., Auer, S., Bergh, S., Fischer, C.E., Gerritsen, D., Grossberg, G., Ismail, Z., Lanctôt, K., Lapid, M.I., Mintzer, J., Palm, R., Rosenberg, P.B., Splaine, M., Zhong, K. and Zhu, C.W. (2023) Reduction and Prevention of Agitation in Persons with Neurocognitive Disorders: An International Psychogeriatric Association Consensus Algorithm. International Psychogeriatrics. https://doi.org/10.1017/S104161022200103X
|
[13]
|
Lee, J.Y., Lee, K.H. and McConnell, E.S. (2021) Mealtime Caregiving Approaches and Behavioral Symptoms in Persons Living with Dementia: A Longitudinal, Observational Study. BMC Nursing, 20, Article No. 104.
https://doi.org/10.1186/s12912-021-00621-3
|
[14]
|
Gillis, K., Lahaye, H., Dom, S., Lips, D., Arnouts, H. and Van Bogaert, P. (2019) A Person-Centred Team Approach Targeting Agitatedand Aggressive Behaviouramongst Nursing Home Residents with Dementia Using the Senses Framework. International Journal of Older People Nursing, 14, e12269. https://doi.org/10.1111/opn.12269
|
[15]
|
Fillit, H., Aigbogun, M.S., Gagnon-Sanschagrin, P., Cloutier, M., Davidson, M., Serra, E., Guérin, A., Baker, R.A., Houle, C.R. and Grossberg, G. (2021) Impact of Agitation in Long-Term Care Residents with Dementia in the United States. International Journal of Geriatric Psychiatry, 36, 1959-1969. https://doi.org/10.1002/gps.5604
|
[16]
|
Tapiainen, V., Lavikainen, P., Koponen, M., Taipale, H., Tan-skanen, A., Tiihonen, J., Hartikainen, S. and Tolppanen, A.M. (2020) The Risk of Head Injuries Associated with Anti-psychotic Use among Persons with Alzheimer’s Disease. Journal of the American Geriatrics Society, 68, 595-602. https://doi.org/10.1111/jgs.16275
|
[17]
|
Mitchell, S.L., Shaffer, M.L., Loeb, M.B., Givens, J.L., Habtemariam, D., Kiely, D.K. and D’Agata, E. (2014) Infection Management and Multidrug-Resistant Organisms in Nursing Home Resi-dents with Advanced Dementia. JAMA Internal Medicine, 174, 1660-1667. https://doi.org/10.1001/jamainternmed.2014.3918
|
[18]
|
D’Onofrio, G., Sancarlo, D., Panza, F., Copetti, M., Cas-cavilla, L., Paris, F., Seripa, D., Matera, M.G., Solfrizzi, V., Pellegrini, F. and Pilotto, A. (2012) Neuropsychiatric Symptoms and Functional Status in Alzheimer’s Disease and Vascular Dementia Patients. Current Alzheimer Research, 9, 759-771. https://doi.org/10.2174/156720512801322582
|
[19]
|
Kitamura, T., Kitamura, M., Hino, S., Tanaka, N. and Kurata, K. (2012) Gender Differences in Clinical Manifestations and Outcomes among Hospitalized Patients with Behavioral and Psychological Symptoms of Dementia. The Journal of Clinical Psychiatry, 73, 1548-1554. https://doi.org/10.4088/JCP.11m07614
|
[20]
|
Orengo, C.A., Khan, J., Kunik, M.E., Snow, A.L., Morgan, R., Steele, A., Cully, J.A. and Graham, D.P. (2008) Aggression in Individuals Newly Diagnosed with Dementia. American Journal of Alzheimer’s Disease and Other Dementias, 23, 227-232. https://doi.org/10.1177/1533317507313373
|
[21]
|
Anatchkova, M., Brooks, A., Swett, L., Hartry, A., Duffy, R.A., Baker, R.A., Hammer-Helmich, L. and Sanon Aigbogun, M. (2019) Agitation in Patients with Dementia: A Systematic Review of Epidemiology and Association with Severity and Course. International Psychogeriatrics, 31, 1305-1318. https://doi.org/10.1017/S1041610218001898
|
[22]
|
Belenchia, E.J. (2023) An Individualized Music Listening Pro-gram to Reduce Agitation in Hospitalized Patients with Alzheimer’s Disease and Related Dementias. Geriatric Nursing, 52, 157-164.
https://doi.org/10.1016/j.gerinurse.2023.06.003
|
[23]
|
Tekin, S., Mega, M.S., Masterman, D.M., Chow, T., Garakian, J., Vinters, H.V. and Cummings, J.L. (2001) Orbitofrontal and Anterior Cingulate Cortex Neurofibrillary Tangle Burden Is Associated with Agitation in Alzheimer Disease. Annals of Neurology, 49, 355-361. https://doi.org/10.1002/ana.72
|
[24]
|
Weissberger, G.H., Melrose, R.J., Narvaez, T.A., Harwood, D., Mandelkern, M.A. and Sultzer, D.L. (2017) 18F-Fluorodeoxyglucose Positron Emission Tomography Cortical Metabolic Activity As-sociated with Distinct Agitation Behaviors in Alzheimer Disease. The American Journal of Geriatric Psychiatry, 25, 569-579.
https://doi.org/10.1016/j.jagp.2017.01.017
|
[25]
|
Sweet, R.A., Pollock, B.G., Sukonick, D.L., Mulsant, B.H., Rosen, J., Klunk, W.E., Kastango, K.B., DeKosky, S.T. and Ferrell, R.E. (2001) The 5-HTTPR Polymorphism Confers Liability to a Combined Phenotype of Psychotic and Aggressive Behavior in Alzheimer Disease. International Psychogeriatrics, 13, 401-409.
https://doi.org/10.1017/S1041610201007827
|
[26]
|
De Mauleon, A., Delrieu, J., Cantet, C., Vellas, B., Andrieu, S., Rosenberg, P.B., Lyketsos, C.G. and Soto Martin, M. (2021) Longitudinal Course of Agitation and Aggression in Pa-tients with Alzheimer’s Disease in a Cohort Study: Methods, Baseline and Longitudinal Results of the A3C Study. The Journal of Prevention of Alzheimer’s Disease, 8, 199-209. https://doi.org/10.14283/jpad.2020.66
|
[27]
|
Ganage, A., Nagrale, N. and Bankar, N. (2022) A Clinical and Basic Science Review of Alzheimer’s Disease. International Journal of Health Sciences, 6, 682-688. https://doi.org/10.53730/ijhs.v6nS2.5049
|
[28]
|
Hegedüs, L., Bianco, A.C., Jonklaas, J., Pearce, S.H., Weetman, A.P. and Perros, P. (2022) Primary Hypothyroidism and Quality of Life. Nature Reviews Endocrinology, 18, 230-242. https://doi.org/10.1038/s41574-021-00625-8
|
[29]
|
Shahid, M.A., Ashraf, M.A. and Sharma, S. (2023) Physiology, Thyroid Hormone. Stat Pearls, Treasure Island.
|
[30]
|
Bavarsad, K., Hosseini, M., Hadjzadeh, M.A. and Sahebkar, A. (2019) The Effects of Thyroid Hormones on Memory Impairment and Alzheimer’s Disease. Journal of Cellular Physiology, 234, 14633-14640.
https://doi.org/10.1002/jcp.28198
|
[31]
|
Kim, J.H., Lee, H.S., Kim, Y.H., Kwon, M.J., Kim, J.H., Min, C.Y., Yoo, D.M. and Choi, H.G. (2022) The Association between Thyroid Diseases and Alzheimer’s Disease in a National Health Screening Cohort in Korea. Frontiers in Endocrinology, 13, Article 815063. https://doi.org/10.3389/fendo.2022.815063
|
[32]
|
Naguib, R. and Elkemary, E. (2023) Thyroid Dysfunction and Renal Function: A Crucial Relationship to Recognize. Cureus, 15, e35242. https://doi.org/10.7759/cureus.35242
|
[33]
|
Dolatshahi, M., Salehipour, A., Saghazadeh, A., Sanjeari Moghaddam, H., Aghamollaii, V., Fotouhi, A. and Tafakhori, A. (2023) Thyroid Hormone Levels in Alzheimer Disease: A Systematic Review and Meta-Analysis. Endocrine, 79, 252-272. https://doi.org/10.1007/s12020-022-03190-w
|
[34]
|
Salehipour, A., Dolatshahi, M., Haghshomar, M. and Amin, J. (2023) The Role of Thyroid Dysfunction in Alzheimer’s Disease: A Systematic Review and Meta-Analysis. The Journal of Prevention of Alzheimer’s Disease, 10, 276-286.
https://doi.org/10.14283/jpad.2023.20
|
[35]
|
Calsolaro, V., Bottari, M., Coppini, G., Lemmi, B. and Monzani, F. (2021) Endocrine Dysfunction and Cognitive Impairment. Minerva Endocrinology, 46, 335-349. https://doi.org/10.23736/S2724-6507.20.03295-2
|
[36]
|
Hoseinlar, S.F., Nikanfar, M., Laghousi, D., Darabi, M., Shademan, B. and Nourazarian, A. (2023) Diagnostic Value of ATG5, Apo-Lipoprotein B-48, Thyroid Hormones, and Homocysteine in Patients with Alzheimer’s Disease. Clinical laboratory, 69. https://doi.org/10.7754/Clin.Lab.2022.220614
|
[37]
|
Sawicka-Gutaj, N., Zawalna, N., Gut, P. and Ruchała, M. (2022) Relationship between Thyroid Hormones and Central Nervous System Metabolism in Physiological and Patho-logical Conditions. Pharmacological Reports, 74, 847-858.
https://doi.org/10.1007/s43440-022-00377-w
|
[38]
|
Ren, B., Ma, J., Tao, M., Jing, G., Han, S., Zhou, C., Wang, X. and Wang, J. (2023) The Disturbance of Thyroid-Associated Hormone and Its Receptors in Brain and Blood Circulation Existed in the Early Stage of Mouse Model of Alzheimer’s Disease. Aging, 15, 1591-1602. https://doi.org/10.18632/aging.204570
|
[39]
|
Ge, F., Zhu, D., Tian, M. and Shi, J. (2021) The Role of Thyroid Function in Alzheimer’s Disease. Journal of Alzheimer’s Disease, 83, 1553-1562. https://doi.org/10.3233/JAD-210339
|
[40]
|
Tang, X., Song, Z.H., Wang, D., Yang, J., Augusto Cardoso, M., Zhou, J.B. and Simó, R. (2021) Spectrum of Thyroid Dysfunction and Dementia: A Dose-Response Meta-Analysis of 344,248 Individuals from Cohort Studies. Endocrine Connections, 10, 410-421. https://doi.org/10.1530/EC-21-0047
|
[41]
|
Đapić, B., Schernhammer, E., Haslacher, H., Stögmann, E. and Lehrner, J. (2022) No Effect of Thyroid Hormones on 5-Year Mortality in Patients with Subjective Cognitive Decline, Mild Cog-nitive Disorder, and Alzheimer’s Disease. Journal of Neuroendocrinology, 34, e13107. https://doi.org/10.1111/jne.13107
|
[42]
|
Kim, H.K. and Song, J. (2022) Hypothyroidism and Diabetes-Related De-mentia: Focused on Neuronal Dysfunction, Insulin Resistance, and Dyslipidemia. International Journal of Molecular Sciences, 23, Article 2982.
https://doi.org/10.3390/ijms23062982
|
[43]
|
Sah, R.P., Vidya, C.S., Pereira, P., Jayaram, S., Yadav, A.K. and Sujatha, P. (2023) Elevated Homocysteine Level and Brain Atrophy Changes as Markers to Screen the Alzheimer’s Dis-ease- Case Series. Annals of Geriatric Medicine and Research. https://doi.org/10.4235/agmr.23.0135
|
[44]
|
Folkestad, L., Brandt, F., Lillevang-Johansen, M., Brix, T.H. and Hegedüs, L. (2020) Graves’ Disease and Toxic Nodular Goiter, Aggravated by Duration of Hyperthyroidism, Are Asso-ciated with Alzheimer’s and Vascular Dementia: A Registry-Based Long-Term Follow-Up of Two Large Cohorts. Thy-roid, 30, 672-680.
https://doi.org/10.1089/thy.2019.0672
|
[45]
|
Jonklaas, J. (2023) Hypothyroidism, Lipids, and Lipidomics. Endocrine. https://doi.org/10.1007/s12020-023-03420-9
|
[46]
|
Zhang, M., Ni, W., Zhang, L., Fan, K., Sun, Y., Liu, C. and Xu, S. (2023) Age-Specific Association between Thyroid Autoimmunity and Hypothyroidism in Chinese Adults Aged over 65 Years: A Cross-Sectional Study. Frontiers in Endocrinology, 14, Article 1216308. https://doi.org/10.3389/fendo.2023.1216308
|
[47]
|
Takizawa, C., Thompson, P.L., van Walsem, A., Faure, C. and Maier, W.C. (2015) Epidemiological and Economic Burden of Alzheimer’s Disease: A Systematic Literature Review of Data across Europe and the United States of America. Journal of Alzheimer’s disease, 43, 1271-1284. https://doi.org/10.3233/JAD-141134
|
[48]
|
Tan, Z.S. and Vasan, R.S. (2009) Thyroid Function and Alzheimer’s Disease. Journal of Alzheimer’s Disease, 16, 503-507. https://doi.org/10.3233/JAD-2009-0991
|
[49]
|
Eslami-Amirabadi, M. and Sajjadi, S.A. (2021) The Relation between Thyroid Dysregulation and Impaired Cognition/Behaviour: An Integrative Review. Journal of Neuroendocrinology, 33, e12948. https://doi.org/10.1111/jne.12948
|
[50]
|
Marouli, E., Yusuf, L., Kjaergaard, A.D., Omar, R., Kuś, A., Baba-jide, O., Sterenborg, R., Åsvold, B.O., Burgess, S., Ellervik, C., Teumer, A., Medici, M. and Deloukas, P. (2021) Thy-roid Function and the Risk of Alzheimer’s Disease: A Mendelian Randomization Study. Thyroid, 31, 1794-1799. https://doi.org/10.1089/thy.2021.0321
|
[51]
|
Li, G.H., Cheung, C.L., Cheung, E.Y., Chan, W.C. and Tan, K.C. (2021) Genetically Determined TSH Level within Reference Range Is Inversely Associated with Alzheimer Disease. The Journal of Clinical Endocrinology and Metabolism, 106, e5064-e5074. https://doi.org/10.1210/clinem/dgab527
|
[52]
|
Teng, Z., Feng, J. and Lv, P. (2023) Subclinical Hypothyroidism Is Associated with Cognitive Impairment in Patients with Cerebral Small Vessel Disease. Neuropsychiatric Disease and Treatment, 19, 303-310.
https://doi.org/10.2147/NDT.S401020
|
[53]
|
Chaalal, A., Poirier, R., Blum, D., Laroche, S. and Enderlin, V. (2019) Thyroid Hormone Supplementation Restores Spatial Memory, Hippocampal Markers of Neuroinflammation, Plastici-ty-Related Signaling Molecules, and β-Amyloid Peptide Load in Hypothyroid Rats. Molecular Neurobiology, 56, 722-735. https://doi.org/10.1007/s12035-018-1111-z
|
[54]
|
Khaleghzadeh-Ahangar, H., Talebi, A. and Mohseni-Moghaddam, P. (2022) Thyroid Disorders and Development of Cognitive Impairment: A Review Study. Neu-roendocrinology, 112, 835-844. https://doi.org/10.1159/000521650
|
[55]
|
Kalmijn, S., Mehta, K.M., Pols, H.A., Hofman, A., Drexhage, H.A. and Breteler, M.M. (2000) Subclinical Hyperthyroidism and the Risk of Dementia. The Rotterdam Study. Clinical Endocrinology, 53, 733-737.
https://doi.org/10.1046/j.1365-2265.2000.01146.x
|
[56]
|
Li, Y.H., Peng, X.D., Huang, C.Q., Yang, B. and Liu, Q.X. (2013) Hypothalamic-Pituitary-Thyroid Axis in Patients with Alzheimer Disease (AD). Journal of Investigative Medicine, 61, 578-581.
https://doi.org/10.2310/JIM.0b013e318280aafb
|
[57]
|
Tan, B., Babur, E., Toy, N., Günaydın, B., Dursun, N. and Süer, C. (2022) Tau Protein Is Differentially Phosphorylated in Young- and Old-Aged Rats with Experimentally Induced Hyperthyroidism. International Journal of Developmental Neuroscience, 82, 654-663. https://doi.org/10.1002/jdn.10220
|
[58]
|
Li, L.X., Yang, T., Guo, L., Wang, D.Y., Tang, C.H., Li, Q., Yang, H.M., Zhu, J. and Zhang, L.L. (2020) Serum Tau Levels Are Increased in Patients with Hyperthyroidism. Neuroscience Letters, 729, Article ID: 135003.
https://doi.org/10.1016/j.neulet.2020.135003
|
[59]
|
Mandegaran, R., Conway, C. and Elton, C. (2013) Lower Gas-trointestinal Adverse Effects of NSAIDS: An Extreme Example of a Common Problem. BMJ Case Reports, 2013, bcr2012008274. https://doi.org/10.1136/bcr-2012-008274
|
[60]
|
Annerbo, S. and Lökk, J. (2013) A Clinical Review of the Association of Thyroid Stimulating Hormone and Cognitive Impairment. ISRN Endocrinology, 2013, Article ID: 856017. https://doi.org/10.1155/2013/856017
|
[61]
|
Furuto-Kato, S., Araki, A., Chiba, Y., Nakamura, M., Shintani, M., Kuwahara, T., Yamakage, H., Satoh-Asahara, N. and Tagami, T. (2022) Relationship between the Thyroid Function and Cognitive Impairment in the Elderly in Japan. Internal Medicine, 61, 3029-3036. https://doi.org/10.2169/internalmedicine.9034-21
|
[62]
|
Wu, Y., Pei, Y., Wang, F., Xu, D. and Cui, W. (2016) Higher FT4 or TSH below the Normal Range Are Associated with Increased Risk of Dementia: A Meta-Analysis of 11 Studies. Scientific Reports, 6, Article No. 31975.
https://doi.org/10.1038/srep31975
|
[63]
|
van Vliet, N.A., van Heemst, D., Almeida, O.P., Åsvold, B.O., Aubert, C.E., Bae, J.B., Barnes, L.E., Bauer, D.C., Blauw, G.J., Brayne, C., Cappola, A.R., Ceresini, G., Comijs, H.C., Dartigues, J.F., Degryse, J.M., Dullaart, R.P.F., van Eersel, M.E.A., den Elzen, W.P.J., Ferrucci, L., Fink, H.A. and Thyroid Studies Collaboration (2021) Association of Thyroid Dysfunction with Cognitive Function: An Individual Par-ticipant Data Analysis. JAMA Internal Medicine, 181, 1440-1450. https://doi.org/10.1001/jamainternmed.2021.5078
|